Abnormal GSK-3α and GSK-3β activities have been associated with multiple diseases including diabetes, inflammation, cancer, bipolar disorder and neurodegenerative diseases including Parkinson’s disease (PD), Alzheimer’s disease (AD) and Huntington’s disease (HD)9–13. The gene discussed is GSK3A; the disease is Huntington disease.